Ozanimod in UC
Adalimumab originator vs biosimilar in CD
Adalimumab high dose+azathioprine vs ADA alone in CD strictures
COVID infection in IBD
Mediterranean diet or Simple Carbohydrate Diet in CD
Exclusive enteral nutrition in ASUC
Adalimumab in paediatric UC
Olamkicept in IBD
Etrolizumab vs infliximab in UC
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial